Compare ARDX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | ESTA |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2014 | 2018 |
| Metric | ARDX | ESTA |
|---|---|---|
| Price | $5.49 | $65.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $15.14 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 3.5M | 482.2K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.67 |
| EPS | ★ N/A | N/A |
| Revenue | $2,607,000.00 | ★ $61,208,000.00 |
| Revenue This Year | $38.22 | $28.04 |
| Revenue Next Year | $33.85 | $26.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 76.49 |
| 52 Week Low | $3.50 | $26.56 |
| 52 Week High | $8.40 | $83.31 |
| Indicator | ARDX | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.52 | 38.35 |
| Support Level | $4.81 | $63.74 |
| Resistance Level | $6.23 | $70.31 |
| Average True Range (ATR) | 0.26 | 2.97 |
| MACD | -0.05 | -0.79 |
| Stochastic Oscillator | 13.07 | 22.31 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.